{
  "docId": "019de074-2e24-777e-87b3-831358a7e33a",
  "docSlug": "971513439f6499291689438a6a6dd75f",
  "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 20 slides",
  "authorId": "compass-therapeutics",
  "authorName": "Compass Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 4,
  "pageCount": 20,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "appendix_methodology",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The slide outlines a standard Simon 2-stage design, a common statistical framework in oncology trials to allow for early stopping for futility.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-2e24-777e-87b3-831358a7e33a/4",
  "deckHref": "/decks/019de074-2e24-777e-87b3-831358a7e33a",
  "deckJsonHref": "/decks/019de074-2e24-777e-87b3-831358a7e33a.json",
  "deckAnchorHref": "/decks/019de074-2e24-777e-87b3-831358a7e33a#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.33,
        "w": 0.44,
        "x": 0.52,
        "y": 0.4
      },
      "kind": "diagram",
      "text": "Stage 2: CTX-009 at 10 mg/kg biweekly, Paclitaxel 80 mg/m2 weekly 3 of 4 weeks, N = 45 additional patients",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "21a3c54b-384d-4986-91a3-2e86fe143bf4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.33,
        "w": 0.44,
        "x": 0.04,
        "y": 0.4
      },
      "kind": "diagram",
      "text": "Stage 1: CTX-009 at 10 mg/kg biweekly, Paclitaxel 80 mg/m2 weekly 3 of 4 weeks, N = 21",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f45c9784-082c-4dcb-8fcf-87b539572288",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.065,
        "w": 0.946,
        "x": 0.027,
        "y": 0.318
      },
      "kind": "framework",
      "text": "Simon 2 Stage adaptive design",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ee020f32-f6a3-44e8-a886-46da108af76b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.08,
        "x": 0.46,
        "y": 0.58
      },
      "kind": "legend",
      "text": "3 or more PRs",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dcc5e617-750f-4aac-a9ef-e675aa54c8ed",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.58,
        "x": 0.21,
        "y": 0.25
      },
      "kind": "paragraph",
      "text": "Patients with biliary tract cancers after one or two prior therapies",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cf1a879d-9de1-474a-a731-0af690a49541",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.68,
        "x": 0.035,
        "y": 0.15
      },
      "kind": "title",
      "text": "Phase 2 CTX-009 Combination Study (S. Korea)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cd3b3809-5585-4895-974a-f1b50717f27e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "simon-2-stage-design",
      "slug": null,
      "matchId": "24956b46-bf99-4726-9815-1feedf689d02",
      "evidence": "Explicitly stated in the header of the study design box.",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 8,
      "from": 3,
      "beatId": "d33bd1e8-59e3-4285-9fff-5d07e1436828",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Product",
      "beatSlug": "sequoia-pitch-product",
      "evidence": "Slides 3-8 detail the product, CTX-009, and its clinical trial data.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}